Committee Agenda for Public Health and Human Services Committee 09/24/2015

CITY OF WORCESTER

Public Health and Human Services Committee Meeting

Thursday, September 24, 2015

Esther Howland (South) Chamber

Convened: 5:31 P.M.

Adjourned: 7:29 PM

Mayor Joseph M. Petty	www.worcesterma.gov	Clerk of the City Council David J. Rushford
Committee Members
Chairperson Sarai Rivera
Councilor Michael T Gaffney
Councilor Philip P Palmieri

City Hall - 455 Main Street Worcester, Massachusetts

	Present Were:	Chairperson Councilor Sarai Rivera Councilor Michael T Gaffney Councilor Philip P Palmieri

	Also:	Chief of Community Health Karyn Clark; Regional Substance Abuse Coordinator Cassandra Andersen; Medical Director Michael P. Hirsch; Appointed Director of Public Health Dr. Matilde Castiel; Assistant City Clerk Susan M. Ledoux, clerk

1.

Communication of the City Manager



	1a.	Communication of the City Manager transmitting informational communication relative to an update on the Opioid Overdose Prevention Plan. # 9.17A CM August 11, 2015	Attachments

		Recommend Hold Speakers: Ronal Madnick, Worcester resident; District Attorney Joseph Early; Wilson Montalvo; Linda Parham, Worcester resident; Athena Haddon, Worcester resident; Terry Kelly, Worcester resident; Jo Hart

		Chairman's Orders
		Request the City Manager request the School Administration to meet with City Council’s Standing Committee on Public Health and Human Services to discuss ways to reach out to the city’s youth and provide information to assist in preventing drug abuse and addiction as well as providing resources to find treatment.
		Request the City Manager request the District Attorney’s Opiod Overdose Task Forces invite providers of addiction treatment facilities to discuss concerns regarding their practice of discharging patients who have broken minor infractions to rules.
		Request City Manager improve inter-departmental communications regarding the use of Narcan so that information is easily shared and includes more detail such as reporting what was outcome after administering this drug for better analysis.